MTCR Skyrocketed
Fri, Sep 24, 2021 at 05:30 PM
MTCR (MTCR:NASDAQ) soared at $3.72, representing a gain of 21.2%. On Thu, Sep 23, 2021, MTCR:NASDAQ touched a New 2-Week Intraday High of $3.17. The stock appeared on our News Catalysts scanner on Thu, Sep 09, 2021 at 08:54 AM in the 'BIOTECH' category. From Thu, Sep 09, 2021, the stock recorded 50.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About MTCR (MTCR:NASDAQ)
Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases.
Top 10 Gainers:
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 36.9%
- Aehr Test Systems (AEHR:NASDAQ), 34.3%
- FLGC (FLGC:NASDAQ), 33.72%
- Meredith Corporation (MDP:NYSE), 25.42%
- GOEV (GOEV:NASDAQ), 21.83%
- MTCR (MTCR:NASDAQ), 21.17%
- NISN (NISN:NASDAQ), 19.92%
- Marin Software Incorporated (MRIN:NASDAQ), 19.56%
- ACHL (ACHL:NASDAQ), 16.81%
- Natuzzi S.p.A. (NTZ:NYSE), 15.26%